JP7754490B2 - アジュバント組成物 - Google Patents

アジュバント組成物

Info

Publication number
JP7754490B2
JP7754490B2 JP2021561492A JP2021561492A JP7754490B2 JP 7754490 B2 JP7754490 B2 JP 7754490B2 JP 2021561492 A JP2021561492 A JP 2021561492A JP 2021561492 A JP2021561492 A JP 2021561492A JP 7754490 B2 JP7754490 B2 JP 7754490B2
Authority
JP
Japan
Prior art keywords
adjuvant
vitamin
vaccine
antigen
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021561492A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021107013A1 (https=
Inventor
英啓 福山
亮太 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kansai Medical University Educational Corp
Original Assignee
Kansai Medical University Educational Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansai Medical University Educational Corp filed Critical Kansai Medical University Educational Corp
Publication of JPWO2021107013A1 publication Critical patent/JPWO2021107013A1/ja
Priority to JP2025113411A priority Critical patent/JP2025143420A/ja
Application granted granted Critical
Publication of JP7754490B2 publication Critical patent/JP7754490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021561492A 2019-11-29 2020-11-26 アジュバント組成物 Active JP7754490B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025113411A JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019216835 2019-11-29
JP2019216835 2019-11-29
PCT/JP2020/044027 WO2021107013A1 (ja) 2019-11-29 2020-11-26 アジュバント組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025113411A Division JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Publications (2)

Publication Number Publication Date
JPWO2021107013A1 JPWO2021107013A1 (https=) 2021-06-03
JP7754490B2 true JP7754490B2 (ja) 2025-10-15

Family

ID=76129420

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021561492A Active JP7754490B2 (ja) 2019-11-29 2020-11-26 アジュバント組成物
JP2025113411A Pending JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025113411A Pending JP2025143420A (ja) 2019-11-29 2025-07-04 アジュバント組成物

Country Status (2)

Country Link
JP (2) JP7754490B2 (https=)
WO (1) WO2021107013A1 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536339A (ja) 1999-02-02 2002-10-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 細菌毒性におけるｄｎａメチル化の必須な役割に基づいて病原性細菌感染を処置および予防するための組成物および方法
JP2010539918A (ja) 2007-09-26 2010-12-24 サノフィ・パスツール インフルエンザウイルスの製造方法
JP2012246259A (ja) 2011-05-30 2012-12-13 Japan Health Science Foundation Ｈ５ｎ１型インフルエンザワクチン及び感染防御キット
US20130011437A1 (en) 2011-07-05 2013-01-10 Life Spring Immuno Science Corp. Immune compositions for treating H. pylori infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795872A (en) * 1995-09-19 1998-08-18 Pharmadigm, Inc. DNA construct for immunization

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536339A (ja) 1999-02-02 2002-10-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 細菌毒性におけるｄｎａメチル化の必須な役割に基づいて病原性細菌感染を処置および予防するための組成物および方法
JP2010539918A (ja) 2007-09-26 2010-12-24 サノフィ・パスツール インフルエンザウイルスの製造方法
JP2012246259A (ja) 2011-05-30 2012-12-13 Japan Health Science Foundation Ｈ５ｎ１型インフルエンザワクチン及び感染防御キット
US20130011437A1 (en) 2011-07-05 2013-01-10 Life Spring Immuno Science Corp. Immune compositions for treating H. pylori infection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
市川文彦ほか，くすりの解説 マキサカルシトール，ファルマシア，2003年，vol.39, no.10，p.967-969

Also Published As

Publication number Publication date
JPWO2021107013A1 (https=) 2021-06-03
JP2025143420A (ja) 2025-10-01
WO2021107013A1 (ja) 2021-06-03

Similar Documents

Publication Publication Date Title
AU2014234316B2 (en) Allergen preparation
JP2003523310A (ja) 新規インフルエンザウイルスワクチン組成物
JPH07504683A (ja) Ｇｍ−ｃｓｆのワクチンアジュバントとしての利用
CN101489589A (zh) 免疫原性组合物
JP6941566B2 (ja) 固定化ウイルス粒子を含むワクチン
AU2026201375A1 (en) Treatment of urticaria
CN112094341B (zh) 抗新型冠状病毒的IgY中和抗体及其制备方法、制剂和应用
KR20160105813A (ko) 알레르기성 병태의 치료에 사용하기 위한 조성물
JP7754490B2 (ja) アジュバント組成物
CN101980721B (zh) 含有合成肽的抗原药物赋形剂和使用其的粘膜疫苗
KR20110011685A (ko) 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법
WO2021222196A1 (en) Methods and compositions relating to ionic liquid adjuvants
US20220257752A1 (en) New use of cyclic dinucleotides
AU2007228736B2 (en) Intranasal influenza vaccine based on virosomes
EP2514438B1 (en) ADJUVANT CONTAINING ß-HEMATIN
DE69609739T2 (de) Pertussistoxin enthaltender Influenzaimpfstoff
US20210338575A1 (en) Dry pharmaceutical composition for inhalation
Lee et al. The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants
WO2021045073A1 (ja) 鼻腔にウイルス特異的抗体を誘導可能な季節性インフルエンザワクチン
WO2020045155A1 (ja) 免疫寛容誘導剤及びアレルギー性疾患の治療又は予防剤
BR102018005192A2 (pt) Globulina imune, método para preparar uma globulina imune, método para tratar infecção, método para fornecer imunoterapia e composição de plasma agrupado
JP7337389B2 (ja) ヒアルロン酸を有効成分として含むアレルゲン作用増強剤
AU2004235815A1 (en) Vaccinating against infectious diseases using proteosomes
Seiler et al. BCG versus VCN: The antigenicity and the adjuvant effect of both compounds
CN117042776A (zh) 疫苗佐剂

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220524

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231116

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20231116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20231116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250704

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250909

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250925

R150 Certificate of patent or registration of utility model

Ref document number: 7754490

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150